Abstract
A large volume of laboratory and human epidemiological studies have shown that high doses of ionizing radiation engender significant health risks. In contrast, the health risks of low level radiation remain ambiguous and have been the subject of intense debate. To reduce the uncertainty in evaluating these risks, research advances in cellular and molecular biology are being used to characterize the biological effects of low dose radiation exposures and their underlying mechanisms. Radiation type, dose rate, genetic susceptibility, cellular redox environment, stage of cell growth, level of biological organization and environmental parameters are among the factors that modulate interactions among signaling processes that determine short- and long-term outcomes of low dose exposures. Whereas, recommended radiation protection guidelines assume a linear dose-response relationship in estimating radiation cancer risk,
in vitro
and
in vivo
investigations of phenomena such as adaptive responses and non-targeted effects, namely bystander effects and genomic instability, suggest that low dose/low fluence-induced signaling events act to alter linearity of the dose-response relation as supported by the biophysical argument. The latter predicts that increases in dose simply increase the probability that a given cell in a tissue will be intersected by an electron track, and by corollary, each unit of radiation, no matter how small would increases risk. These predictions assume that similar molecular events mediate both low and high dose radiobiological effects, and the cumulative risk from two sequential radiation exposures can never be less than one alone.